This is a randomized prospective clinical study that will evaluate the effects of antenatal
corticosteroid administration (ACS) vs. placebo in singleton pregnancies who are threatening
to deliver prematurely between 22 0/7 and 23 6/7 weeks on admission with the goal of
improving composite neonatal mortality and morbidity.
Phase:
Phase 3
Details
Lead Sponsor:
Mednax Center for Research, Education and Quality Mednax Center for Research, Education, Quality and Safety